Release Date: 29/11/17 18:41 Summary: Proposed Admission to AIM Price Sensitive: No Download Document 402.09KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%